Tuesday, November 26, 2019 5:04:01 PM
There's a sucker born every minute!
-Some Circus Dude
Recent ARVN News
- Arvinas to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/29/2024 11:00:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:16:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 11:33:09 AM
- Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200 • GlobeNewswire Inc. • 07/22/2024 12:30:00 PM
- Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer • GlobeNewswire Inc. • 06/24/2024 08:37:13 PM
- Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2 • GlobeNewswire Inc. • 06/21/2024 11:00:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:53:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:51:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:55:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 11:03:14 AM
- Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer • GlobeNewswire Inc. • 06/17/2024 11:00:03 AM
- Arvinas to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 06/03/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 09:52:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:52:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 01:48:00 AM
- Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress • GlobeNewswire Inc. • 05/23/2024 09:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 10:05:26 AM
- Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) • GlobeNewswire Inc. • 05/16/2024 10:00:45 AM
- Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress • GlobeNewswire Inc. • 05/09/2024 08:42:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:13:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:02:45 AM
- Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/07/2024 11:00:11 AM
- Arvinas to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer • GlobeNewswire Inc. • 04/24/2024 08:30:38 PM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM